Document Detail


Early and innovative interventions for severe sepsis and septic shock: taking advantage of a window of opportunity.
MedLine Citation:
PMID:  16247103     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The pathogenic, diagnostic and therapeutic landscape of sepsis is no longer confined to the intensive care unit: many patients from other portals of entry to care, both outside and within the hospital, progress to severe disease. Approaches that have led to improved outcomes with other diseases (e.g., acute myocardial infarction, stroke and trauma) can now be similarly applied to sepsis. Improved understanding of the pathogenesis of severe sepsis and septic shock has led to the development of new therapies that place importance on early identification and aggressive management. This review emphasizes approaches to the early recognition, diagnosis and therapeutic management of sepsis, giving the clinician the most contemporary and practical approaches with which to treat these patients.
Authors:
Emanuel P Rivers; Lauralyn McIntyre; David C Morro; Kandis K Rivers
Related Documents :
9988003 - Shock timing lowers transvenous defibrillation energy requirement.
16290963 - Applicability of clinical prediction models in acute myocardial infarction: a compariso...
22044033 - Pre-procedural elevated white blood cell count and neutrophil-lymphocyte (n/l) ratio ar...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne     Volume:  173     ISSN:  1488-2329     ISO Abbreviation:  CMAJ     Publication Date:  2005 Oct 
Date Detail:
Created Date:  2005-10-25     Completed Date:  2005-11-15     Revised Date:  2010-09-21    
Medline Journal Info:
Nlm Unique ID:  9711805     Medline TA:  CMAJ     Country:  Canada    
Other Details:
Languages:  eng     Pagination:  1054-65     Citation Subset:  AIM; IM    
Affiliation:
Department of Emergency Medicine, Henry Ford Hospital, Detroit, Mich, USA. erivers1@hfhs.org
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Anti-Bacterial Agents / therapeutic use
Cell Hypoxia
Diagnosis, Differential
Disease Progression
Fluid Therapy
Humans
Intensive Care Units
Microcirculation
Oxygen / metabolism
Risk Factors
Sepsis / diagnosis,  physiopathology,  prevention & control*,  therapy
Shock, Septic / diagnosis,  physiopathology,  prevention & control*,  therapy
Time Factors
Chemical
Reg. No./Substance:
0/Anti-Bacterial Agents; 7782-44-7/Oxygen
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Efficacy of an extract of North American ginseng containing poly-furanosyl-pyranosyl-saccharides for...
Next Document:  No resting place: African American women at the crossroads of violence.